Klára Grantz Šašková

1.0k total citations
25 papers, 779 citations indexed

About

Klára Grantz Šašková is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Klára Grantz Šašková has authored 25 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Infectious Diseases and 11 papers in Virology. Recurrent topics in Klára Grantz Šašková's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and Ubiquitin and proteasome pathways (4 papers). Klára Grantz Šašková is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and Ubiquitin and proteasome pathways (4 papers). Klára Grantz Šašková collaborates with scholars based in Czechia, Germany and United States. Klára Grantz Šašková's co-authors include Jan Konvalinka, Milan Kožíšek, Pavlína Řezáčová, J. Brynda, Martin Lepšı́k, Jana Pokorná, Petr Cígler, Michal Svoboda, Bohumı́r Grüner and J. Plešek and has published in prestigious journals such as Journal of Molecular Biology, Advanced Functional Materials and Journal of Virology.

In The Last Decade

Klára Grantz Šašková

23 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klára Grantz Šašková Czechia 17 308 267 228 194 182 25 779
Juraj Sedláček Czechia 18 507 1.6× 340 1.3× 360 1.6× 451 2.3× 231 1.3× 59 1.2k
Elisabeth K. Nyakatura Germany 13 399 1.3× 175 0.7× 54 0.2× 94 0.5× 302 1.7× 23 811
Michaela Wendeler United States 18 548 1.8× 160 0.6× 127 0.6× 120 0.6× 187 1.0× 37 858
Anne‐Marie Faucher Canada 19 376 1.2× 300 1.1× 239 1.0× 61 0.3× 675 3.7× 27 1.4k
Andrew Spaltenstein United States 21 498 1.6× 274 1.0× 202 0.9× 72 0.4× 591 3.2× 35 1.2k
Peter W. White Canada 21 417 1.4× 287 1.1× 57 0.3× 111 0.6× 219 1.2× 46 1.3k
Anoma Somasunderam United States 19 563 1.8× 112 0.4× 89 0.4× 41 0.2× 155 0.9× 43 1.0k
Elisabetta Pilotti Italy 16 215 0.7× 106 0.4× 150 0.7× 50 0.3× 143 0.8× 28 840
Robert A. Domaoal United States 19 400 1.3× 388 1.5× 320 1.4× 70 0.4× 248 1.4× 29 888
H. M. Krishna Murthy United States 14 403 1.3× 138 0.5× 74 0.3× 42 0.2× 89 0.5× 23 892

Countries citing papers authored by Klára Grantz Šašková

Since Specialization
Citations

This map shows the geographic impact of Klára Grantz Šašková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klára Grantz Šašková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klára Grantz Šašková more than expected).

Fields of papers citing papers by Klára Grantz Šašková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klára Grantz Šašková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klára Grantz Šašková. The network helps show where Klára Grantz Šašková may publish in the future.

Co-authorship network of co-authors of Klára Grantz Šašková

This figure shows the co-authorship network connecting the top 25 collaborators of Klára Grantz Šašková. A scholar is included among the top collaborators of Klára Grantz Šašková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klára Grantz Šašková. Klára Grantz Šašková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plecitá‐Hlavatá, Lydie, et al.. (2025). STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction. Cell Death Discovery. 11(1). 494–494.
2.
Sedláĉek, Jindr̂ich, et al.. (2025). Small-molecule activators of NRF1 transcriptional activity prevent protein aggregation. Biomedicine & Pharmacotherapy. 183. 117864–117864. 2 indexed citations
3.
Sedláĉek, Jindr̂ich, et al.. (2025). Investigating NFE2L1 activators for targeted protein aggregate clearance: a follow-up study. RSC Medicinal Chemistry. 16(12). 6397–6411.
4.
Sedláĉek, Jindr̂ich, et al.. (2025). Targeting NFE2L1 signalling with small molecules to protect against Ferroptosis. Bioorganic & Medicinal Chemistry Letters. 130. 130425–130425. 1 indexed citations
5.
Venz, Simone, František Sedlák, Kallayanee Chawengsaksophak, et al.. (2024). DDI2 protease controls embryonic development and inflammation via TCF11/NRF1. iScience. 27(10). 110893–110893. 1 indexed citations
6.
Vaněk, Václav, František Sedlák, Jan Procházka, et al.. (2021). Lipid Nanoparticles for Broad‐Spectrum Nucleic Acid Delivery. Advanced Functional Materials. 31(47). 19 indexed citations
7.
Srb, Pavel, Michal Svoboda, Ladislav Benda, et al.. (2019). Capturing a dynamically interacting inhibitor by paramagnetic NMR spectroscopy. Physical Chemistry Chemical Physics. 21(10). 5661–5673. 20 indexed citations
8.
Svoboda, Michal, Jan Konvalinka, Jean‐François Trempe, & Klára Grantz Šašková. (2019). The yeast proteases Ddi1 and Wss1 are both involved in the DNA replication stress response. DNA repair. 80. 45–51. 32 indexed citations
9.
Ramírez, Juanma, Benoît Lectez, Nerea Osinalde, et al.. (2018). Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome. Human Molecular Genetics. 27(11). 1955–1971. 23 indexed citations
10.
Trempe, Jean‐François, Klára Grantz Šašková, Colin D.H. Ratcliffe, et al.. (2016). Structural studies of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic protein family. Scientific Reports. 6(1). 33671–33671. 35 indexed citations
11.
Svoboda, Michal, Václav Veverka, Jean‐François Trempe, et al.. (2016). Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog. Scientific Reports. 6(1). 44 indexed citations
12.
Kožíšek, Milan, Martin Lepšı́k, Klára Grantz Šašková, et al.. (2014). Thermodynamic and structural analysis of HIV protease resistance to darunavir – analysis of heavily mutated patient‐derived HIV‐1 proteases. FEBS Journal. 281(7). 1834–1847. 46 indexed citations
13.
Šašková, Klára Grantz, Milan Kožíšek, Kirsten M. Stray, et al.. (2013). GS-8374, a Prototype Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits Protease Mutants with Amino Acid Insertions. Journal of Virology. 88(6). 3586–3590. 7 indexed citations
14.
Kožíšek, Milan, Klára Grantz Šašková, Graeme Brendon Jacobs, et al.. (2012). Mutations in HIV-1gagandpolCompensate for the Loss of Viral Fitness Caused by a Highly Mutated Protease. Antimicrobial Agents and Chemotherapy. 56(8). 4320–4330. 34 indexed citations
15.
Schimer, Jiří, Petr Cígler, Ján Veselý, et al.. (2012). Structure-Aided Design of Novel Inhibitors of HIV Protease Based on a Benzodiazepine Scaffold. Journal of Medicinal Chemistry. 55(22). 10130–10135. 56 indexed citations
16.
Kožíšek, Milan, et al.. (2009). Backbone 1H, 13C, and 15N NMR assignment for the inactive form of the retroviral protease of the murine intracisternal A-type particle, inMIA-14 PR. Biomolecular NMR Assignments. 3(2). 261–264. 5 indexed citations
17.
Řezáčová, Pavlína, Jana Pokorná, J. Brynda, et al.. (2009). Design of HIV Protease Inhibitors Based on Inorganic Polyhedral Metallacarboranes. Journal of Medicinal Chemistry. 52(22). 7132–7141. 125 indexed citations
18.
Šašková, Klára Grantz, Milan Kožíšek, Martin Lepšı́k, et al.. (2008). Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Protein Science. 17(9). 1555–1564. 19 indexed citations
19.
Král, Vlastimil, Irena Sieglová, J. Brynda, et al.. (2008). Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies. Antiviral Research. 78(3). 275–277. 6 indexed citations
20.
Kožíšek, Milan, Pavlína Řezáčová, Klára Grantz Šašková, et al.. (2007). Molecular Analysis of the HIV-1 Resistance Development: Enzymatic Activities, Crystal Structures, and Thermodynamics of Nelfinavir-resistant HIV Protease Mutants. Journal of Molecular Biology. 374(4). 1005–1016. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juraj Sedláček Breakdown of academic impact, for papers by Elisabeth K. Nyakatura Breakdown of academic impact, for papers by Michaela Wendeler Breakdown of academic impact, for papers by Anne‐Marie Faucher Breakdown of academic impact, for papers by Andrew Spaltenstein Breakdown of academic impact, for papers by Peter W. White Breakdown of academic impact, for papers by Anoma Somasunderam Breakdown of academic impact, for papers by Elisabetta Pilotti Breakdown of academic impact, for papers by Robert A. Domaoal Breakdown of academic impact, for papers by H. M. Krishna Murthy
Rankless by CCL
2026